Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.6200
+0.0390 (6.71%)
At close: Apr 24, 2026, 4:00 PM EDT
0.6400
+0.0200 (3.23%)
After-hours: Apr 24, 2026, 7:59 PM EDT
Fractyl Health Employees
Fractyl Health had 100 employees as of December 31, 2025. The number of employees decreased by 7 or -6.54% compared to the previous year.
Employees
100
Change
-7
Growth
-6.54%
Revenue / Employee
n/a
Profits / Employee
-$1,409,540
Market Cap
98.36M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 100 | -7 | -6.54% |
| Sep 30, 2025 | 101 | -21 | -17.21% |
| Jun 30, 2025 | 103 | -9 | -8.04% |
| Mar 31, 2025 | 109 | -2 | -1.80% |
| Dec 31, 2024 | 107 | 5 | 4.90% |
| Sep 30, 2024 | 122 | 34 | 38.64% |
| Jun 30, 2024 | 112 | 19 | 20.43% |
| Mar 31, 2024 | 111 | 18 | 19.35% |
| Dec 31, 2023 | 102 | - | - |
| Sep 30, 2023 | 88 | - | - |
| Jun 30, 2023 | 93 | - | - |
| Dec 31, 2021 | 83 | - | - |
| Sep 30, 2021 | 73 | - | - |
| Jun 30, 2021 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Inovio Pharmaceuticals | 112 |
| Adicet Bio | 102 |
| PolyPid | 75 |
| Rani Therapeutics Holdings | 71 |
| eXoZymes | 32 |
| Q32 Bio | 24 |
| ProMIS Neurosciences | 11 |
GUTS News
- 4 weeks ago - Fractyl Health Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026 - GlobeNewsWire
- 2 months ago - Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight Maintenance - GlobeNewsWire
- 3 months ago - Fractyl Health, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – GUTS - Business Wire
- 3 months ago - Fractyl Health Shares Drop, Eyes New FDA Route For Its Lead Product - Benzinga
- 3 months ago - Fractyl Health Transcript: Study result - Transcripts
- 3 months ago - Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 Discontinuation - GlobeNewsWire
- 3 months ago - Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness - GlobeNewsWire